Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 81 for your search:
Drug:  anti-thymocyte globulin
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Approved-not yet active
Age: 21 and under
Sponsor: Other
Protocol IDs: TASMC-11-MB-442-CTIL, NCT01339988

2.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 40 to 60
Sponsor: Other
Protocol IDs: 2013-08, NCT01856803

3.

Phase: Phase IV
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 18 to 60
Sponsor: Other
Protocol IDs: 2013(56), NCT02290132

4.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 1 to 50
Sponsor: Other
Protocol IDs: HORCSCT-0902, NCT01015742

5.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: ATGFamilyStudy, NCT00678275

6.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 19 and under
Sponsor: Other
Protocol IDs: ProfGVHD1, NCT00934557

7.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 60 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000659585, ECOG-E2906, E2906, NCT01041703

8.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 16 to 70
Sponsor: Other
Protocol IDs: CBMTG 0801, NCT01217723

9.

Phase: Phase III
Type: Treatment
Status: Active
Age: 15 to 65
Sponsor: Other
Protocol IDs: C-021, NCT01145976

10.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Under 30
Sponsor: NCI
Protocol IDs: NCI-2011-02670, COG-AAML1031, CDR0000701850, AAML1031, U10CA098543, U10CA180886, NCT01371981

11.

Phase: Phase III
Type: Treatment
Status: Active
Age: 3 to 70
Sponsor: Other
Protocol IDs: 2011-0628, NCI-2012-00038, NCT01471444

12.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: CBMTC-AML-1, NCT01751997

13.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 17 to 70
Sponsor: Other
Protocol IDs: 2067.00, NCI-2011-01352, R01AI041721, FHCRC-2067.00, 6364, NCT00622895

14.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Under 60
Sponsor: Other
Protocol IDs: MT2000-09, 0001M34441, UMN-MT2000-09, UMN-2007BMT031, NCT00630253

15.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: CCI #07-00119, CHLA-#07-00119, NCT00730314

16.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 30 and under
Sponsor: Other
Protocol IDs: AAAA5185, CHNY-01-501, NCT00802113

17.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: SCT 0208, NCT00679536

18.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: AMCPHO-SCT0902, NCT01509300

19.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2012-0249, NCI-2012-01248, NCT01629511

20.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2012-0265, NCI-2012-02072, NCT01664910

21.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 12 to 65
Sponsor: Other
Protocol IDs: 2012-0506, NCI-2012-02055, NCT01701986

22.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 65 and under
Sponsor: Other
Protocol IDs: 2012-0819, RP110553-P3), NCI-2013-00993, NCT01823198

23.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: NHLBI
Protocol IDs: CDR0000066610, NHLBI-97-H-0196, NCT00003553

24.

Phase: Phase II
Type: Treatment
Status: Active
Age: 8 to 80
Sponsor: NHLBI
Protocol IDs: 990050, 99-H-0050, NHLBI-99-H-0050, NCT00003838

25.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2003.332, NCT00129155
1     
New Search